Hy2Care (Grant)
Funding Details
- Awarder
- RSS - tech.eu
- Date Award
- May 16, 2025
- Vertical
- Medtech
- Funding URL
- View Funding Page
- Funding Amount:
- $4,500,000
Company Info
- Traction
- Received FDA Investigational Device Exemption (IDE) approval to begin clinical evaluation of CartRevive in the U.S.
- Company Description
- Hy2Care is a medtech company focused on developing CartRevive, a proprietary hydrogel implant designed to repair damaged cartilage in a minimally invasive way, offering a potential alternative to more invasive surgical treatments.
- Market
- Cartilage repair
- Location
- Netherlands
- Coinvestors
- European Innovation Council Fund, Brightlands Venture Partners, LIOF